bilarmed@bilarmed.com | +90 (216) 456 66 99 | +90 (216) 456 71 79

MateRegen Gel

mate

MateRegen Gel is a cross-linked hyaluronic acid gel material developed to prevent intrauterine adhesions. The gel structure enables controlled degradation and optimum viscosity. It is completely organic thanks to the self-cross-linked hyaluronic acid structure and does not contain any substances harmful to the body or artificial chemicals.

Multiple proven functions of MateRegen Gel:

• Prevents adhesion and scarring
• Minimizes bleeding and edema
• Facilitates re-mucosalization
• Eliminates post-op removal due to biosorption
• Avoids secondary damage to the mucous
• Conforms to the uterine cavity without dead space

It is also proven that MateRegen Gel is able to significantly reduce postoperative intrauterine adhesions when it is used for patients after miscarriage, resection of myoma and other intrauterine procedures.

FDA CE 

MateRegen® Gel is developed using a proprietary thiolated chemistry to crosslink the non-animal sourced HA molecules. The modification/crosslinking is well controlled so that the cross-linked HA gel has adequate degradation profile and viscosity to match the critical period of tissue repair processes and is able to prevent adhesion.

*BioRegen has  FDA approval for PureRegen Gel Sinus and PureRegen Gel OTO.

You may have access to the information of patents owned by BioRegen-BioMedical Company here.